91 related articles for article (PubMed ID: 8096852)
21. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
[TBL] [Abstract][Full Text] [Related]
22. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
23. [Mechanism mediating HIV replication in infected individuals].
Kannagi M
Rinsho Byori; 1990 Apr; 38(4):426-30. PubMed ID: 2195196
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection.
Aldhous MC; Watret KC; Mok JY; Bird AG; Froebel KS
Clin Exp Immunol; 1994 Jul; 97(1):61-7. PubMed ID: 8033422
[TBL] [Abstract][Full Text] [Related]
25. Suppression of HIV-1 replication by HIV-1-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-1-infected cells in vitro.
Liu H; Ohashi T; Masuda T; Zhou X; Kubo M; Kannagi M
Viral Immunol; 2003; 16(3):381-93. PubMed ID: 14583152
[TBL] [Abstract][Full Text] [Related]
26. HIV-specific CD8+ T-cell immune responses and viral replication.
Buseyne F; Rivière Y
AIDS; 1993 Nov; 7 Suppl 2():S81-5. PubMed ID: 7909230
[TBL] [Abstract][Full Text] [Related]
27. CD8 T-cell-mediated inhibition of HIV replication in HIV infected adults and children.
Plaeger-Marshall S; Hausner MA; Isacescu V; Giorgi JV
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1375-6. PubMed ID: 1281656
[No Abstract] [Full Text] [Related]
28. Inverse relationship of CD8+CD11+ suppressor T cells with human immunodeficiency virus (HIV)-specific cellular cytotoxicity and natural killer cell activity in HIV infection.
Kundu SK; Merigan TC
Immunology; 1991 Dec; 74(4):567-71. PubMed ID: 1686022
[TBL] [Abstract][Full Text] [Related]
29. Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers.
Buseyne F; Burgard M; Teglas JP; Bui E; Rouzioux C; Mayaux MJ; Blanche S; Rivière Y
AIDS Res Hum Retroviruses; 1998 Nov; 14(16):1435-44. PubMed ID: 9824321
[TBL] [Abstract][Full Text] [Related]
30. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers.
De Maria A; Cirillo C; Moretta L
J Infect Dis; 1994 Nov; 170(5):1296-9. PubMed ID: 7963731
[TBL] [Abstract][Full Text] [Related]
31. In vitro measurement of cytotoxic T cell activity does not predict clinical progression in paediatric HIV disease--two case studies.
Froebel KS; Mok JY; Aldhous MC; Armitage MP; Arnott M; Reynolds LM; Peutherer JF; Burns SM
Clin Exp Immunol; 1997 Oct; 110(1):15-21. PubMed ID: 9353143
[TBL] [Abstract][Full Text] [Related]
32. Dual mechanisms of lymphocyte-mediated cytotoxicity serve to control and deliver the immune response.
Smyth MJ
Bioessays; 1995 Oct; 17(10):891-8. PubMed ID: 7487970
[TBL] [Abstract][Full Text] [Related]
33. T-cell induced pathogenesis in HIV: bystander effects and latent infection.
Krakauer DC; Nowak M
Proc Biol Sci; 1999 May; 266(1423):1069-75. PubMed ID: 10380683
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV.
Rivière Y; Buseyne F
Vaccine; 1998; 16(14-15):1420-2. PubMed ID: 9711782
[TBL] [Abstract][Full Text] [Related]
35. Immunologic targets of HIV infection: T cells. NICHD IVIG Clinical Trial Group, and the NHLBI P2C2 Pediatric Pulmonary and Cardiac Complications of HIV Infection Study Group.
Shearer WT; Rosenblatt HM; Schluchter MD; Mofenson LM; Denny TN
Ann N Y Acad Sci; 1993 Oct; 693():35-51. PubMed ID: 7903519
[TBL] [Abstract][Full Text] [Related]
36. Cytolytic response to HIV in patients with HIV disease treated with extracorporeal photochemotherapy: preliminary study.
Gonzalez J; Berger C; Cottrill CM; Geller A; Schwartz J; Palangio M; Klainer AS; Bisaccia E
Photochem Photobiol; 1996 May; 63(5):558-61. PubMed ID: 8628744
[TBL] [Abstract][Full Text] [Related]
37. Cytolytic T-cell activity against mycobacterial antigens in HIV.
Forte M; Maartens G; Rahelu M; Pasi J; Ellis C; Gaston H; Kumararatne D
AIDS; 1992 Apr; 6(4):407-11. PubMed ID: 1377474
[TBL] [Abstract][Full Text] [Related]
38. HIV-specific cytotoxic T lymphocytes against alveolar macrophages: specificities and downregulation.
Autran B; Sadat-Sowti B; Hadida F; Parrot A; Guillon JM; Plata F; Mayaud C; Debré P
Res Virol; 1991; 142(2-3):113-8. PubMed ID: 1832781
[TBL] [Abstract][Full Text] [Related]
39. T lymphocytes and their cytokines in human immunodeficiency virus (HIV) infection: implications for associated neoplasias.
Jassoy C; Walker BD
Crit Rev Oncog; 1995; 6(3-6):275-89. PubMed ID: 9012587
[TBL] [Abstract][Full Text] [Related]
40. Cytolytic CD4(+) T cells in viral immunity.
Soghoian DZ; Streeck H
Expert Rev Vaccines; 2010 Dec; 9(12):1453-63. PubMed ID: 21105780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
